EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Corrigendum to “Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies” [Cancer Treat. Rev. 139 (2025) 102980]

Federica Giugliano, Carmine De Angelis, Barbara Pistilli, Giulia Viale, Giampaolo Bianchini, Mario Giuliano, Luca Malorni, Beatrice Taurelli Salimbeni, Angela Esposito, Antonio Giordano, Timothy A Yap, Giuseppe Curigliano und 1 weitere

Cancer Treatment Reviews · 2026-12 · 151 · 103238

DOI: 10.1016/j.ctrv.2026.103238 ↗

Kurz gefasst

Korrektur in der Zeitschrift Cancer Treatment Reviews, 2026-12. Verfasst von Federica Giugliano und 12 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U981, Gustave Roussy, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Oncology and Hematol…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • INSERM U981, Gustave Roussy, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Oncology and Hematology-Oncology, University of Milano, Milan, Italy.
  • Clinical and Translational Oncology, Scuola Superiore Meridionale, Via Mezzocannone, 4, 80134 Naples, Italy.
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France; INSERM U1279, Gustave Roussy, Villejuif, France.
  • Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
  • Translational Research Unit, Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.

Zitieren

APA

Giugliano, F., De Angelis, C., Pistilli, B., Viale, G., Bianchini, G., Giuliano, M., Malorni, L., Salimbeni, B. T., Esposito, A., Giordano, A., Yap, T. A., Curigliano, G., & Criscitiello, C. (2026). Corrigendum to “Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies” [Cancer Treat. Rev. 139 (2025) 102980]. Cancer Treatment Reviews, 151, 103238. https://doi.org/10.1016/j.ctrv.2026.103238

Vancouver

Giugliano F, De Angelis C, Pistilli B, Viale G, Bianchini G, Giuliano M, et al. Corrigendum to “Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies” [Cancer Treat. Rev. 139 (2025) 102980]. Cancer Treatment Reviews. 2026;151:103238. doi:10.1016/j.ctrv.2026.103238

BibTeX
@article{Giugliano2026,
  author = {Giugliano, Federica and De Angelis, Carmine and Pistilli, Barbara and Viale, Giulia and Bianchini, Giampaolo and Giuliano, Mario and Malorni, Luca and Salimbeni, Beatrice Taurelli and Esposito, Angela and Giordano, Antonio and Yap, Timothy A and Curigliano, Giuseppe and Criscitiello, Carmen},
  title = {Corrigendum to “Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies” [Cancer Treat. Rev. 139 (2025) 102980]},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {151},
  pages = {103238},
  doi = {10.1016/j.ctrv.2026.103238}
}
Kostenlos starten →